InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $4.100 0.02 (0.49%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,467 4DMedical and Philips sign Memorandum of Understanding 29 Nov 2023 9:35AM $0.920 $4.100 risen by 345.65%
$2,467 Application for quotation of securities - 4DX 24 Nov 2023 1:57PM $0.920 $4.100 risen by 345.65%
$2,467 4DX signs SaaS contracts to expand into Detroit & Memphis 22 Nov 2023 8:52AM $0.670 $4.100 risen by 511.94%
$2,467 4DMedical receives U.S. FDA clearance for CT LVAS 20 Nov 2023 9:05AM $0.655 $4.100 risen by 525.95%
$2,467 Presentation to Bell Potter Healthcare Conference 13 Nov 2023 6:39PM $0.785 $4.100 risen by 422.29%
$2,467 U.S. CMS Approves Reimbursement for 4DMedical 13 Nov 2023 8:59AM $0.460 $4.100 risen by 791.30%
$2,467 Notification regarding unquoted securities - 4DX 6 Nov 2023 11:45AM $0.465 $4.100 risen by 781.72%
$2,467 Change of Director's Interest Notice 6 Nov 2023 11:37AM $0.470 $4.100 risen by 772.34%
$2,467 Constitution 2 Nov 2023 3:54PM $0.465 $4.100 risen by 781.72%
$2,467 Final Director's Interest Notice 2 Nov 2023 3:49PM $0.475 $4.100 risen by 763.16%
$2,467 Results of Meeting 2 Nov 2023 3:45PM $0.475 $4.100 risen by 763.16%
$2,467 AGM presentation and Chairman's address 2 Nov 2023 8:20AM $0.490 $4.100 risen by 736.73%
$2,467 Final Director's Interest Notice 1 Nov 2023 1:40PM $0.475 $4.100 risen by 763.16%
$2,467 Resignation of non-executive director 1 Nov 2023 1:32PM $0.475 $4.100 risen by 763.16%
$2,467 Quarterly Activity Report and Appendix 4C for Q1 FY2024 31 Oct 2023 9:04AM $0.495 $4.100 risen by 728.28%
$2,467 4DMedical enters contract with Integral Diagnostics 30 Oct 2023 9:05AM $0.470 $4.100 risen by 772.34%
$2,467 Application for quotation of securities - 4DX 26 Oct 2023 11:07AM $0.480 $4.100 risen by 754.17%
$2,467 Notification regarding unquoted securities - 4DX 26 Oct 2023 11:01AM $0.480 $4.100 risen by 754.17%
$2,467 Application for quotation of securities - 4DX 20 Oct 2023 10:01AM $0.490 $4.100 risen by 736.73%
$2,467 Application for quotation of securities - 4DX 11 Oct 2023 10:12AM $0.490 $4.100 risen by 736.73%
$2,467 Notification of cessation of securities - 4DX 4 Oct 2023 3:11PM $0.490 $4.100 risen by 736.73%
$2,467 Notification regarding unquoted securities - 4DX 4 Oct 2023 3:05PM $0.490 $4.100 risen by 736.73%
$2,467 Appointment and retirement of Chair 3 Oct 2023 12:07PM $0.520 $4.100 risen by 688.46%
$2,467 Notice of Annual General Meeting/Proxy Form 28 Sep 2023 9:49AM $0.500 $4.100 risen by 720%
$2,467 Initial Director's Interest Notice 25 Sep 2023 10:16AM $0.535 $4.100 risen by 666.36%

351 - 375 of 603 results

Page 15 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.